posted on 2015-06-11, 03:20authored byAda H. V. Repetto-Llamazares, Roy H. Larsen, Sebastian Patzke, Karianne G. Fleten, David Didierlaurent, Alexandre Pichard, Jean Pierre Pouget, Jostein Dahle
(A) Uptake of 177Lu-HH1 (N = 6–8), 177Lu-rituximab (N = 4–5), 177Lu-IgG1 control (N = 5) in selected organs/tissues from nude mice with Ramos xenografts in percentage of injected activity per gram of tissue (%IA/g). Error bars = standard error. *: Significantly different from 177Lu-HH1 (One-way ANOVA with Holm Sidak method for multiple comparisons, p < 0.05). (B) Dose rate per MBq of injected activity in selected organs of nude mice with Ramos xenografts treated with 177Lu-HH1 (N = 6–8) and 177Lu-rituximab (N = 4–5). (C) In vivo SPECT/CT multiplanar rendered view of a nude mouse with a Ramos xenograft in its right flank injected with 10 MBq of 177Lu-HH1.